Add thelocalreport.in As A Trusted Source
A form of nicotenmide, Vitamin B People can reduce the risk by visiting the counter in pharmacies skin cancer Returning after repairing DNA Disadvantages according to new research.
A study conducted on more than 33,000 people who survived skin cancer found that taking oral nicotinamide reduced the risk by 14 percent.
Those who started taking it after skin cancer first saw a decrease of 54 percent in risk DiagnosisBut people who had had skin cancer many times reduced this rate.
One of the authors of the study, Professor Lee Veeles, a dermatology, said: “What we saw was that the sooner you start taking it in the journey of skin cancer, the better it will do.
“(Skin cancer) is a very common and, fortunately, not a very high mortality cancer, but skin cancer’s sickness is very much, very high. There are many patients in which multiple skin cancer develops.”
The study used data from more than 33,000 US giants, which had skin cancer in the past. More than 12,000 patients took 500 mg nicotinumide twice a day for more than 30 days, and compared to more than 21,000 patients did not consume it.
Mr. Veeles said that it is believed that nicotinamide can improve the skin ability to repair DNA damage caused by ultraviolet radiation, and can also reduce the immunity generated from ultraviolet radiation.
“So if we are repairing the damage rapidly and we are not preventing the immune system from cleaning cancerous cells, it will reduce the risk of skin cancer,” he said.
“If our background damage is low, and we are slowing down the rate of new damage, then it will take longer to return to that extent for the development of new skin cancer.”
.jpeg)
The study identified the greatest risk decrease of the dermal squamous cell carcinoma, the second most common type of skin cancer in the UK. It did not pay attention to melanoma or any other type of skin cancer.
According to Cancer Research UK, England have about 155,000 cases of non-melonoma skin cancer every year.
Charity has previously warned that although research has suggested such Nicotinamide The return of the disease may slow down, but it will not protect you from the sun.
Since skin cancer referrals are steadily increasing in the UK, NHS is using new measures of identity. This year, it was deployed A artificial intelligence screening equipment Which analyzes the images of wounds and detects symptoms of potential skin cancer. Technology has been conditionally approved for the next three years and more than 200,000 patients have been evaluated in NHS.
This technique is one of the many methods that continue to employ the UK health sector AI. earlier this year, A researcher from the University of Herriot-Wat in Edinburgh A similar system is developed that allows a patient to take a picture of his skin, which is analyzed by AI, and then returned with a diagnosis.